CANCER SUPPORT
1300 881 698
CANCER SUPPORT | 1300 881 698
New PBAC application supports immunotherapy treatment for oesophageal and gastro-oesophageal junction cancers
Nikki Rynia
Pancare is supporting Bristol Meyers Squibb in their application to the Pharmaceutical Benefits Advisory Committee (PBAC) for the funding of Nivolumab, an immunotherapy for the treatment of
Advocating for upper GI cancers: oesophageal and gastric cancer update
An important part of Pancare supporting patients with upper gastrointestinal (GI) cancers is advocating for better treatment and unmet needs.
$20 million funding boost gives new hope for Australians impacted by pancreatic cancer
Pancare Foundation welcomes the Australian Government’s delivery of the Pancreatic Cancer Roadmap and the commitment of $20.3 million to support improved outcomes and survival for Australians
Implantable drug-eluting device: pancreatic cancer research update
This multidisciplinary research collaboration has brought together leaders in Cancer Biology and Therapeutics, Oncology, and Biomedical Material Science in a project that has developed a novel drug
Upper gastrointestinal cancer incidence on the rise
Thanks to the generous support of the GPA Andrew Ursini Charitable Fund, Pancare continues to fund the Novel Therapies Program for pancreatic cancer at the University of Melbourne.
Major funder supports research into new treatments for pancreatic cancer
New Pancare Foundation scholarship winners announced
The Pancare Foundation proudly welcomes a new pair of Pancare Scholarship winners for the 2021 award round. Congratulations Dr Michael Kuan-Ching Lee and Ms Antonia Cadell.
Research co-funding commitment inspires top cholangiocarcinoma research ideas
Last month the Australasian Gastro-Intestinal Trials Group (AGITG) and Pancare Foundation co-hosted an exceptional Ideas Generation Workshop to develop new research ideas for the rare and devastating
